These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23515197)

  • 1. Consensus panel's assessment and recommendations on the use of 3 botulinum toxin type A products in facial aesthetics.
    Lorenc ZP; Kenkel JM; Fagien S; Hirmand H; Nestor MS; Sclafani AP; Sykes JM; Waldorf HA
    Aesthet Surg J; 2013 Mar; 33(1 Suppl):35S-40S. PubMed ID: 23515197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 3 Commercially Available Botulinum Toxin Neuromodulators on Facial Synkinesis: A Randomized Clinical Trial.
    Thomas AJ; Larson MO; Braden S; Cannon RB; Ward PD
    JAMA Facial Plast Surg; 2018 Mar; 20(2):141-147. PubMed ID: 28973094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of Botulinum Toxins for Aesthetic Uses.
    Gart MS; Gutowski KA
    Clin Plast Surg; 2016 Jul; 43(3):459-71. PubMed ID: 27363760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromodulators for Skin.
    Costeloe A; Nguyen A; Maas C
    Facial Plast Surg Clin North Am; 2023 Nov; 31(4):511-519. PubMed ID: 37806684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of onabotulinumtoxinA (Botox).
    Lorenc ZP; Kenkel JM; Fagien S; Hirmand H; Nestor MS; Sclafani AP; Sykes JM; Waldorf HA
    Aesthet Surg J; 2013 Mar; 33(1 Suppl):9S-12S. PubMed ID: 23515199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Aesthetics Consensus: Botulinum Toxin Type A--Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications.
    Sundaram H; Signorini M; Liew S; Trindade de Almeida AR; Wu Y; Vieira Braz A; Fagien S; Goodman GJ; Monheit G; Raspaldo H;
    Plast Reconstr Surg; 2016 Mar; 137(3):518e-529e. PubMed ID: 26910696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of AbobotulinumtoxinA (Dysport).
    Lorenc ZP; Kenkel JM; Fagien S; Hirmand H; Nestor MS; Sclafani AP; Sykes JM; Waldorf HA
    Aesthet Surg J; 2013 Mar; 33(1 Suppl):13S-7S. PubMed ID: 23515194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations.
    Carruthers JDA; Glogau RG; Blitzer A;
    Plast Reconstr Surg; 2008 May; 121(5 Suppl):5S-30S. PubMed ID: 18449026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to achieve synergy between volume replacement and filling products for global facial rejuvenation.
    Raspaldo H; Aziza R; Belhaouari L; Berros P; Body S; Galatoire O; Le Louarn C; Michaud T; Niforos F; Rousseaux I; Runge M; Taieb M
    J Cosmet Laser Ther; 2011 Apr; 13(2):77-86. PubMed ID: 21401381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aesthetic Uses of Neuromodulators: Current Uses and Future Directions.
    Gart MS; Gutowski KA
    Plast Reconstr Surg; 2015 Nov; 136(5 Suppl):62S-71S. PubMed ID: 26441114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations.
    Kane M; Donofrio L; Ascher B; Hexsel D; Monheit G; Rzany B; Weiss R
    J Drugs Dermatol; 2010 Jan; 9(1 Suppl):s7-22; quiz s23-5. PubMed ID: 20919448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the use of botulinum neurotoxins in facial esthetics.
    Flynn TC
    J Cosmet Dermatol; 2012 Mar; 11(1):42-50. PubMed ID: 22360334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A for aging face and aesthetic uses.
    Hexsel C; Hexsel D; Porto MD; Schilling J; Siega C
    Dermatol Ther; 2011; 24(1):54-61. PubMed ID: 21276158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global 3-dimensional approach to natural rejuvenation: recommendations for perioral, nose, and ear rejuvenation.
    Gassia V; Raspaldo H; Niforos FR; Michaud T
    J Cosmet Dermatol; 2013 Jun; 12(2):123-36. PubMed ID: 23725306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six years of experience using an advanced algorithm for botulinum toxin application.
    Casabona G; Kaye K; Barreto Marchese P; Boggio R; Cotofana S
    J Cosmet Dermatol; 2019 Feb; 18(1):21-35. PubMed ID: 30536548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?
    Kapoor R; Shome D; Jain V; Dikshit R
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.
    Wilson AJ; Chang B; Taglienti AJ; Chin BC; Chang CS; Folsom N; Percec I
    Plast Reconstr Surg; 2016 May; 137(5):1424-1433. PubMed ID: 27119918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IncobotulinumtoxinA (Xeomin): background, mechanism of action, and manufacturing.
    Lorenc ZP; Kenkel JM; Fagien S; Hirmand H; Nestor MS; Sclafani AP; Sykes JM; Waldorf HA
    Aesthet Surg J; 2013 Mar; 33(1 Suppl):18S-22S. PubMed ID: 23515195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IncobotulinumtoxinA in clinical literature.
    Lorenc ZP; Kenkel JM; Fagien S; Hirmand H; Nestor MS; Sclafani AP; Sykes JM; Waldorf HA
    Aesthet Surg J; 2013 Mar; 33(1 Suppl):23S-34S. PubMed ID: 23515196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.